{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:46:04Z","timestamp":1778071564977,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":146,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.transproceed.2022.04.023","type":"journal-article","created":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T05:22:08Z","timestamp":1662873728000},"page":"1874-1880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Minimal Development of Liver Fibrosis in Adult Tolerant Liver Transplant Recipients Late After Immunosuppressive Drug Weaning and Transplantation"],"prefix":"10.1016","volume":"54","author":[{"given":"Aafke A.","family":"Duizendstra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"De Knegt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.A.","family":"Nagtzaam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel G.H.","family":"Betjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolle H.R.","family":"Litjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap","family":"Kwekkeboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.04.023_bib0001","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1600-6143.2006.01256.x","article-title":"improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data","volume":"6","author":"Futagawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0002","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.26426","article-title":"Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients","volume":"58","author":"Benitez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0003","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/TP.0b013e318195a7cb","article-title":"Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation","volume":"87","author":"Yoshitomi","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0004","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2005.11.047","article-title":"Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence","volume":"44","author":"Tisone","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trim.2008.08.007","article-title":"The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months","volume":"20","author":"Orlando","year":"2008","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0006","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/tri.12023","article-title":"The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up","volume":"26","author":"Manzia","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0007","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ajt.13617","article-title":"Hepatic infiltrates in operational tolerant patients after liver transplantation show enrichment of regulatory T cells before proinflammatory genes are downregulated","volume":"16","author":"Taubert","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0008","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hep.28681","article-title":"Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R","volume":"65","author":"Feng","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0009","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jama.2011.2014","article-title":"Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants","volume":"307","author":"Feng","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0010","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/hep.31520","article-title":"Efficacy and safety of immunosuppression withdrawal in pediatric liver transplant recipients: moving towards personalized management","volume":"73","author":"Feng","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0011","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21151","article-title":"Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC","volume":"43","author":"Corpechot","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0012","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/gut.2007.126417","article-title":"Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"56","author":"Yoneda","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0013","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.clinre.2012.08.002","article-title":"Performances of Elasto-FibroTest\u00ae, a combination between FibroTest\u00ae and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C","volume":"36","author":"Poynard","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0014","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/MCG.0000000000001119","article-title":"Fibroscan reliably rules out advanced liver fibrosis and significant portal hypertension in alcoholic patients","volume":"53","author":"Salavrakos","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0015","first-page":"e16","article-title":"EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, Update 2017 (Long Version) EFSUMB-Leitlinien und Empfehlungen zur klinischen Anwendung der Leberelastographie, Update 2017 (Langversion)","volume":"38","author":"Dietrich","year":"2017","journal-title":"Ultraschall Med"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0016","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1478-3231.2011.02663.x","article-title":"Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C","volume":"32","author":"Verveer","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0017","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/lt.23391","article-title":"Transient elastography identifies liver recipients with nonviral graft disease after transplantation: a guide for liver biopsy","volume":"18","author":"Rigamonti","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0018","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clinre.2012.11.003","article-title":"Non-invasive assessment of liver graft fibrosis by transient elastography after liver transplantation","volume":"37","author":"Barrault","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185192","article-title":"Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: a meta-analysis","volume":"12","author":"Bhat","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0020","doi-asserted-by":"crossref","first-page":"e13700","DOI":"10.1111\/ctr.13700","article-title":"A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post-liver transplant patient","volume":"33","author":"Winters","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0022","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0023","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/lt.25177","article-title":"Prevalence, risk factors, and impact of donor-specific alloantibodies after adult liver transplantation","volume":"24","author":"Vandevoorde","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0024","doi-asserted-by":"crossref","first-page":"eaat9284","DOI":"10.1126\/scitranslmed.aat9284","article-title":"Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis","volume":"11","author":"Yang","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.matbio.2015.03.005","article-title":"The role of TIMPs in regulation of extracellular matrix proteolysis","volume":"44-46","author":"Arpino","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0026","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.matbio.2017.11.011","article-title":"Matrix metalloproteinase functions in hepatic injury and fibrosis","volume":"68-69","author":"Roderfeld","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0027","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis\u2014a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0028","doi-asserted-by":"crossref","first-page":"e13676","DOI":"10.1111\/ctr.13676","article-title":"Tissue inhibitor of metalloproteinase 1 and AST-to-Platelet Ratio Index as noninvasive biomarkers predict allograft fibrosis after pediatric liver transplantation","volume":"33","author":"Beime","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0029","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/tri.12879","article-title":"Liver and serum expression of matrix metalloproteinases in asymptomatic pediatric liver transplant recipients","volume":"30","author":"Voutilainen","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clinbiochem.2015.07.019","article-title":"Hyaluronic acid as a non-invasive biomarker of liver fibrosis","volume":"49","author":"Neuman","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0031","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.transproceed.2008.12.014","article-title":"APRI and FIB-4 scores are useful after liver transplantation independently of etiology","volume":"41","author":"Pissaia","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0032","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.08.003","article-title":"B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis","volume":"56","author":"Francois","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0034","doi-asserted-by":"crossref","first-page":"eaas9944","DOI":"10.1126\/sciadv.aas9944","article-title":"BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance","volume":"4","author":"Matsushita","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0035","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/hep.21152","article-title":"Progressive histological damage in liver allografts following pediatric liver transplantation","volume":"43","author":"Evans","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0036","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/lt.21549","article-title":"Graft histology characteristics in long-term survivors of pediatric liver transplantation","volume":"14","author":"Ekong","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0037","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.22686","article-title":"Graft fibrosis after pediatric liver transplantation: ten years of follow-up","volume":"49","author":"Scheenstra","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0038","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/ajt.12740","article-title":"Dynamics of allograft fibrosis in pediatric liver transplantation","volume":"14","author":"Venturi","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0039","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1053\/j.gastro.2018.08.023","article-title":"Evidence of chronic allograft injury in liver biopsies from long-term pediatric recipients of liver transplants","volume":"155","author":"Feng","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.transproceed.2022.04.023_bib0040","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41598-020-58714-z","article-title":"Risk factors of silent allograft fibrosis 10 years post-pediatric liver transplantation","volume":"10","author":"Rhu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0041","doi-asserted-by":"crossref","first-page":"e13693","DOI":"10.1111\/petr.13693","article-title":"Transforming growth factor beta 1 levels in the blood of pediatric liver recipients: clinical and biochemical correlations","volume":"24","author":"Kurabekova","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0042","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/lt.23481","article-title":"Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance","volume":"18","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0043","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/TP.0000000000003034","article-title":"DSA are associated with more graft injury, more fibrosis, and upregulation of rejection-associated transcripts in subclinical rejection","volume":"104","author":"Hofer","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0044","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2018.06.004","article-title":"Subclinical T cell-mediated liver transplant rejection: the jury is still out","volume":"69","author":"Hutchinson","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0045","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/lt.24427","article-title":"Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts","volume":"22","author":"Baumann","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2022.04.023_bib0046","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2013.03.016","article-title":"The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values","volume":"59","author":"Lichtinghagen","year":"2013","journal-title":"J Hepatol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522004237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522004237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:43:51Z","timestamp":1758577431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134522004237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0041134522004237"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.04.023","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal Development of Liver Fibrosis in Adult Tolerant Liver Transplant Recipients Late After Immunosuppressive Drug Weaning and Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}